JP2019505785A5 - - Google Patents

Download PDF

Info

Publication number
JP2019505785A5
JP2019505785A5 JP2018534930A JP2018534930A JP2019505785A5 JP 2019505785 A5 JP2019505785 A5 JP 2019505785A5 JP 2018534930 A JP2018534930 A JP 2018534930A JP 2018534930 A JP2018534930 A JP 2018534930A JP 2019505785 A5 JP2019505785 A5 JP 2019505785A5
Authority
JP
Japan
Prior art keywords
cdr
antibody
progastrin
amino acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018534930A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019505785A (ja
JP7018885B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/050037 external-priority patent/WO2017114976A1/en
Publication of JP2019505785A publication Critical patent/JP2019505785A/ja
Publication of JP2019505785A5 publication Critical patent/JP2019505785A5/ja
Priority to JP2022013712A priority Critical patent/JP7363007B2/ja
Application granted granted Critical
Publication of JP7018885B2 publication Critical patent/JP7018885B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018534930A 2015-12-31 2017-01-02 食道癌の検出および治療のための組成物および方法 Active JP7018885B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022013712A JP7363007B2 (ja) 2015-12-31 2022-01-31 食道癌の検出および治療のための組成物および方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15307189.9 2015-12-31
EP15307189 2015-12-31
EP16305139.4 2016-02-05
EP16305139 2016-02-05
PCT/EP2017/050037 WO2017114976A1 (en) 2015-12-31 2017-01-02 Compositions and methods for detecting and treating esophageal cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022013712A Division JP7363007B2 (ja) 2015-12-31 2022-01-31 食道癌の検出および治療のための組成物および方法

Publications (3)

Publication Number Publication Date
JP2019505785A JP2019505785A (ja) 2019-02-28
JP2019505785A5 true JP2019505785A5 (cg-RX-API-DMAC7.html) 2020-02-20
JP7018885B2 JP7018885B2 (ja) 2022-02-14

Family

ID=57821946

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018534930A Active JP7018885B2 (ja) 2015-12-31 2017-01-02 食道癌の検出および治療のための組成物および方法
JP2022013712A Active JP7363007B2 (ja) 2015-12-31 2022-01-31 食道癌の検出および治療のための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022013712A Active JP7363007B2 (ja) 2015-12-31 2022-01-31 食道癌の検出および治療のための組成物および方法

Country Status (14)

Country Link
US (2) US11789021B2 (cg-RX-API-DMAC7.html)
EP (2) EP3397967B1 (cg-RX-API-DMAC7.html)
JP (2) JP7018885B2 (cg-RX-API-DMAC7.html)
KR (2) KR102197478B1 (cg-RX-API-DMAC7.html)
CN (2) CN108700589A (cg-RX-API-DMAC7.html)
AU (2) AU2017204686B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018013272A2 (cg-RX-API-DMAC7.html)
CA (2) CA3193481C (cg-RX-API-DMAC7.html)
EA (1) EA037032B1 (cg-RX-API-DMAC7.html)
ES (2) ES2861587T3 (cg-RX-API-DMAC7.html)
PL (1) PL3397967T3 (cg-RX-API-DMAC7.html)
SG (1) SG11201805263TA (cg-RX-API-DMAC7.html)
WO (1) WO2017114976A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201804142B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240018264A1 (en) * 2015-12-31 2024-01-18 Progastrine Et Cancers S.À R.L. Compositions and methods for detecting and treating ovarian cancer
DK3720879T3 (da) * 2017-12-05 2022-06-20 Progastrine Et Cancers S A R L Kombinationsterapi mellem anti-progastrin-antistof og immunterapi til behandling af cancer
US20200390913A1 (en) 2017-12-08 2020-12-17 Ecs-Biotracker Sàrl Radiolabeled progastrin in cancer diagnosis
TW201940881A (zh) 2018-01-26 2019-10-16 瑞士商Ecs前胃泌激素公司 在癌症診斷中結合前胃泌激素檢測與其他癌症生物標記的技術
EP3759492A1 (en) 2018-02-27 2021-01-06 ECS-Progastrin SA Progastrin as a biomarker for immunotherapy
EP3765853B1 (en) * 2018-03-13 2024-05-01 Creatv Microtech, Inc. Methods for monitoring treatment response and disease progression in subjects using circulating cells
KR102167078B1 (ko) * 2019-07-19 2020-10-16 (주)파즈코리아 혈액 샘플 이송 장치
WO2021081498A1 (en) * 2019-10-24 2021-04-29 The Johns Hopkins University Compositions and methods for detecting and treating esophageal cancer
JP7287532B2 (ja) * 2020-08-04 2023-06-06 王子ホールディングス株式会社 トイレットロール

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444887A (en) 1979-12-10 1984-04-24 Sloan-Kettering Institute Process for making human antibody producing B-lymphocytes
US4716111A (en) 1982-08-11 1987-12-29 Trustees Of Boston University Process for producing human antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
GB8924581D0 (en) 1989-11-01 1989-12-20 Pa Consulting Services Bleaching of hair
EP1690935A3 (en) 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化b−b10
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5916771A (en) 1996-10-11 1999-06-29 Abgenix, Inc. Production of a multimeric protein by cell fusion method
EP1972194A1 (en) 1996-12-03 2008-09-24 Amgen Fremont Inc. Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
JP3876002B2 (ja) 1997-04-14 2007-01-31 ミクロメート・アクチエンゲゼルシャフト 抗ヒト抗原受容体を産生するための斬新な方法およびそれらの使用
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
JP2004536835A (ja) * 2001-07-09 2004-12-09 アフトン コーポレーション 肝臓、肺および食道の癌性ならびに前癌性状態の治療および防止
EP2567974A3 (en) 2004-09-22 2013-05-22 Cancer Advances, Inc., Monoclonal antibodies to progastrin
JP2009529915A (ja) * 2006-03-20 2009-08-27 ゾーマ テクノロジー リミテッド ガストリン物質に対して特異的なヒト抗体および方法
US7854932B2 (en) * 2006-12-19 2010-12-21 The Board Of Regents Of The University Of Texas System Immunogenic compositions comprising progastrin and uses thereof
US20110085986A1 (en) * 2009-10-13 2011-04-14 Pomila Singh Diagnosis and treatment of epithelial cancers using labeled/conjugated progastrin peptides
US8900817B2 (en) 2010-01-08 2014-12-02 Les Laboratories Servier Progastrin and liver pathologies
US8900588B2 (en) * 2010-01-08 2014-12-02 Les Laboratories Servier Methods for treating breast cancer
US9217032B2 (en) * 2010-01-08 2015-12-22 Les Laboratoires Servier Methods for treating colorectal cancer
WO2011116954A2 (en) 2010-03-24 2011-09-29 Bioréalités S.A.S. Prophylaxis of colorectal and gastrointestinal cancer
KR101576174B1 (ko) 2010-07-26 2015-12-09 르 라보레또레 쎄르비에르 간암 요법을 위한 방법 및 조성물
FI20145550A7 (fi) * 2014-06-13 2015-12-14 Biohit Oyj Gastriini-17 käyttö biomarkkerina atrofiselle gastriitille ja usealle sen seurauksena kohonneelle riskille
WO2016066671A1 (en) * 2014-10-29 2016-05-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for treating resistant cancers using progastrin inhibitors

Similar Documents

Publication Publication Date Title
US20230295300A1 (en) Antibodies specific to delta 1 chain of t cell receptor
JP7196076B2 (ja) がんの処置のための抗tnf関連アポトーシス誘発リガンド受容体2及び抗カドヘリン17結合性二重特異的分子
EP2997042B1 (en) Anti-cxcl1, cxcl7 and cxcl8 antibodies and their applications
JP2019502923A5 (cg-RX-API-DMAC7.html)
JP7301538B2 (ja) リンパ球における阻害経路の中和
KR20210018311A (ko) Dll3-cd3 이중 특이적 항체
EP4644425A1 (en) Antibody that binds ErbB-2 and ErbB-3
KR20130043168A (ko) 이원 가변 도메인 면역글로불린 및 이의 용도
AU2013355324A1 (en) Blood-brain barrier (BBB) penetrating dual specific binding proteins
CA3156983A1 (en) Antibodies against the poliovirus receptor (pvr) and uses thereof
KR102430893B1 (ko) 식도암을 검출 및 치료하기 위한 조성물 및 방법
JP2023547530A (ja) 抗tigit抗体およびその使用
US20250333506A1 (en) Antibodies specific to delta 1 chain of t cell receptor
JP2019505784A5 (cg-RX-API-DMAC7.html)
US12516133B2 (en) TGFβ/PD-L1 bispecific binding proteins
WO2018067819A1 (en) Compositions and methods for treatment of cancers
KR20240150805A (ko) Sting 효능제를 포함하는 항체 약물 접합체, 조합 및 사용 방법
CN116940597A (zh) 多特异性抗体及其用途
JP2023528223A (ja) 骨髄線維症を処置するための抗ヘモジュベリン(hjv)抗体
US20240052065A1 (en) Binding molecules for the treatment of cancer
US20260130922A1 (en) Methods of treating cancer using an anti-ctla4 antibody and an enpp1 inhibitor
KR20250169623A (ko) 암 치료를 위한 grem1 길항제를 수반하는 조합 요법
HK40117288A (en) Anti-cd40 antibodies and uses thereof
CA3136510A1 (en) Combinations of anti-ildr2 antibodies and pd-1 antagonists